Shanghai-based biotech company developing gene sequencing and in vitro diagnostic products for disease detection.
Based in Shanghai, China and established in 2014, Righton works in biomedical technology and provides gene sequencing products. It maintains cooperative relationships with more than 150 tertiary A hospitals across the country. Its main business covers research, production and sales of in vitro diagnostic products for blood diseases, solid tumors and infectious diseases such as hepatitis B, supporting genetic and antigen detection for individualized treatment plans. The company is at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in